Quercetin potentiates doxorubicin mediated antitumor effects against liver cancer through p53/Bcl-xl.
BACKGROUND: The dose-dependent toxicities of doxorubicin (DOX) limit its clinical applications, particularly in drug-resistant cancers, such as liver cancer. In this study, we investigated the role of quercetin on the antitumor effects of DOX on liver cancer cells and its ability to provide protecti...
Main Authors: | Guanyu Wang, Jiawei Zhang, Luying Liu, Sherven Sharma, Qinghua Dong |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3519886?pdf=render |
Similar Items
Similar Items
-
MDM2-BCL-XL PROTACs enable degradation of BCL-XL and stabilization of p53
by: Mengyang Chang, et al.
Published: (2022-08-01) -
Molecular basis of Bcl-XL-p53 interaction : insights from molecular dynamics simulations
by: Bharatham, Nagakumar, et al.
Published: (2012) -
Bcl-XL but Not Bcl-2 Is a Potential Target in Medulloblastoma Therapy
by: Mike-Andrew Westhoff, et al.
Published: (2022-01-01) -
Targeting BCL-XL in fibrolamellar hepatocellular carcinoma
by: Bassem Shebl, et al.
Published: (2022-09-01) -
P409: BCL-2/BCL-XL INHIBITION INDUCES APOPTOSIS AND CIRCUMVENTS VENETOCLAX RESISTANCE IN TP53-MUTATED ACUTE MYELOID LEUKEMIA
by: Ida Vänttinen, et al.
Published: (2023-08-01)